The first large population-based study to evaluate lower urinary tract symptoms (LUTS) in Poland. The study objective is to assess the prevalence and bother of LUTS in the population aged ≥40 years in Poland.
The first large population-based study to evaluate lower urinary tract symptoms (LUTS) in Poland. The study objective is to assess the prevalence and bother of LUTS in the population aged ≥40 years in Poland. This study will be conducted as a telephone survey with assessment of LUTS using a standardized protocol, which included the International Prostate Symptom Score (IPSS) and, for overactive bladder (OAB), the OAB-V8 questionnaire. Participants will be asked to rate how often they experienced individual LUTS and the degree of associated bother. The study will be performed in a representative group of Polish population (n = 6,000) covering all geographic regions of Poland (defined by the Central Statistical Office of Poland).
Study Type
OBSERVATIONAL
Enrollment
6,000
There will be no intervention
Department of Urology Jagiellonian University
Krakow, Poland
Prevalence of LUTS
The prevalence of LUTS will be assessed using definitions of the International Continence Society (descriptive statistics).
Time frame: Through study completion, an average of 3 months
Symptom bother of LUTS
The degree of associated bother will be assessed using Likert scale (Likert scale: not at all \[score 0\], a little bit \[score 1\], somewhat \[score 2\], quite a bit \[score 3\], a great deal \[score 4\], or a very great deal \[score 5\]).
Time frame: Through study completion, an average of 3 months
Prevalence of specific symptoms
The prevalence of specific symptoms will be assessed using a standardised protocol based on the definitions provided by the International Continence Society (i.e. storage symptoms, voiding symptoms and post-micturition symptoms) \[Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167-178\]. Participants will be asked to rate how often they experienced individual LUTS during the past month. A Likert scale will be used with the following options: none (score 0), \<1 in 5 times (score 1), \<half the time (score 2), about half the time (score 3), \>half the time (score 4), or almost always (score 5).
Time frame: Through study completion, an average of 3 months
Symptom bother of specific symptoms
The degree of associated bother of specific symptoms will be assessed using Likert scale (Likert scale: not at all \[score 0\], a little bit \[score 1\], somewhat \[score 2\], quite a bit \[score 3\], a great deal \[score 4\], or a very great deal \[score 5\]).
Time frame: Through study completion, an average of 3 months
Prevalence of OAB
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The prevalence of OAB will be assessed with the Overactive Bladder-Validated 8-question Screener (OAB-V8)questionnaire.
Time frame: Through study completion, an average of 3 months